Skip Nav Destination
Issues
Editorials
Reviews
The Biology Behind
Featured Articles
Clinical Trials
Crossover Randomized Comparison of Intravenous versus Intravenous/Oral Mesna in Soft Tissue Sarcoma Treated with High-Dose Ifosfamide
Joseph R. Mace; Mary L. Keohan; Heinz Bernardy; Klaus Junge; Georg Niebch; Peter Romeis; Aangelika Thoma; Thomas Wagner; Udo Mueller; George Demetri; Laurence H. Baker
A Phase I Trial of 90Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer
Jeffrey Y. C. Wong; Stephen Shibata; Lawrence E. Williams; Cheuk S. Kwok; An Liu; David Z. Chu; Dave M. Yamauchi; Sharon Wilczynski; David N. Ikle; Anna M. Wu; Paul J. Yazaki; John E. Shively; James H. Doroshow; Andrew A. Raubitschek
Molecular Oncology, Markers, Clinical Correlates
Experimental Therapeutics, Preclinical Pharmacology
Regular Articles
Clinical Trials
Phase I Trial of Intraperitoneal Docetaxel in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity: Dose-Limiting Toxicity and Pharmacokinetics
Robert J. Morgan, Jr.; James H. Doroshow; Timothy Synold; Dean Lim; Stephen Shibata; Kim Margolin; Roderich Schwarz; Lucille Leong; George Somlo; Przemyslaw Twardowski; Yun Yen; Warren Chow; Paul Lin; Benjamin Paz; David Chu; Paul Frankel; Susan Stalter
T-Cell Responses to HLA-A*0201 Immunodominant Peptides Derived from α-Fetoprotein in Patients with Hepatocellular Cancer
Lisa H. Butterfield; Antoni Ribas; Wilson S. Meng; Vivian B. Dissette; Saral Amarnani; Huong T. Vu; Elisabeth Seja; Karen Todd; John A. Glaspy; William H. McBride; James S. Economou
A Phase II Study of the Polyamine Analog N1,N11-Diethylnorspermine (DENSpm) Daily for Five Days Every 21 Days in Patients with Previously Treated Metastatic Breast Cancer
Antonio C. Wolff; Deborah K. Armstrong; John H. Fetting; M. Katherine Carducci; Carol D. Riley; John F. Bender; Robert A. Casero, Jr.; Nancy E. Davidson
Phase I and Correlative Study of Combination Bryostatin 1 and Vincristine in Relapsed B-Cell Malignancies
Afshin Dowlati; Hillard M. Lazarus; Paul Hartman; James W. Jacobberger; Cecilia Whitacre; Stanton L. Gerson; Pamela Ksenich; Brenda W. Cooper; Phyllis S. Frisa; Megan Gottlieb; Anthony J. Murgo; Scot C. Remick
Induction Chemotherapy followed by Concomitant TFHX Chemoradiotherapy with Reduced Dose Radiation in Advanced Head and Neck Cancer
Daniel J. Haraf; Fred R. Rosen; Kerstin Stenson; Athanassios Argiris; Bharat B. Mittal; Mary Ellyn Witt; Bruce E. Brockstein; Marcy A. List; Louis Portugal; Harold Pelzer; Ralph R. Weichselbaum; Everett E. Vokes
Pilot Trial of Trastuzumab Starting with or after the Doxorubicin Component of a Doxorubicin plus Paclitaxel Regimen for Women with HER2-Positive Advanced Breast Cancer
Giulia Bianchi; John Albanell; Wolfgang Eiermann; Giordano Vitali; David Borquez; Lucia Viganò; Rafael Molina; Günter Raab; Alberta Locatelli; Bart Vanhauwere; Luca Gianni; Jose Baselga
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Inverse Correlation between Heparan Sulfate Composition and Heparanase-1 Gene Expression in Thyroid Papillary Carcinomas: A Potential Role in Tumor Metastasis
Xiulong Xu; Roderick M. Quiros; Justin B. Maxhimer; Ping Jiang; Regina Marcinek; Kenneth B. Ain; Jeffrey L. Platt; Jikun Shen; Paolo Gattuso; Richard A. Prinz
Feasibility of Using Low-Volume Tissue Samples for Gene Expression Profiling of Advanced Non-Small Cell Lung Cancers
Elaine H. Lim; Amit Aggarwal; Thirugananam Agasthian; Poo-Sing Wong; Christie Tan; Eugene Sim; Lenny Tan; Poh-Sun Goh; Shih-Chang Wang; Kay-Leong Khoo; Amartya Mukherjee; See-Meng Khoo; Gerald Chua; Barbro Nilsson; Kang-Hoe Lee; Patrick Tan
Experimental Therapeutics, Preclinical Pharmacology
Capecitabine Inhibits Postoperative Recurrence and Metastasis after Liver Cancer Resection in Nude Mice with Relation to the Expression of Platelet-Derived Endothelial Cell Growth Factor
Jian Zhou; Zhao-You Tang; Jia Fan; Zhi-Quan Wu; Yuan Ji; Yong-Sheng Xiao; Ying-Hong Shi; Xiao-Ming Li; Qi-Man Sun; Yin-Kun Liu; Sheng-Long Ye
Combination of Interferon-β and the Angiotensin-Converting Enzyme Inhibitor, Perindopril, Attenuates Murine Hepatocellular Carcinoma Development and Angiogenesis
Ryuichi Noguchi; Hitoshi Yoshiji; Shigeki Kuriyama; Junichi Yoshii; Yasuhide Ikenaka; Koji Yanase; Tadashi Namisaki; Mitsuteru Kitade; Masaharu Yamazaki; Akira Mitoro; Hirohisa Tsujinoue; Hiroo Imazu; Tsutomu Masaki; Hiroshi Fukui
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.